RU2020103225A - Имидазодиазепиновое соединение - Google Patents

Имидазодиазепиновое соединение Download PDF

Info

Publication number
RU2020103225A
RU2020103225A RU2020103225A RU2020103225A RU2020103225A RU 2020103225 A RU2020103225 A RU 2020103225A RU 2020103225 A RU2020103225 A RU 2020103225A RU 2020103225 A RU2020103225 A RU 2020103225A RU 2020103225 A RU2020103225 A RU 2020103225A
Authority
RU
Russia
Prior art keywords
imidazodiazepine
compound
imidazodiazepine compound
diazepin
benzoxazole
Prior art date
Application number
RU2020103225A
Other languages
English (en)
Other versions
RU2777915C2 (ru
RU2020103225A3 (ru
Inventor
Симпей Каваками
Томоеси ИМАИДЗУМИ
Наоюки Масуда
Сигеки Куникава
Масатака МОРИТА
Юнко ЯРИМИДЗУ
Original Assignee
Астеллас Фарма Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астеллас Фарма Инк. filed Critical Астеллас Фарма Инк.
Publication of RU2020103225A publication Critical patent/RU2020103225A/ru
Publication of RU2020103225A3 publication Critical patent/RU2020103225A3/ru
Application granted granted Critical
Publication of RU2777915C2 publication Critical patent/RU2777915C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Claims (2)

1. Кристаллическая форма 4-фтор-3-(2-оксо-2-{2-[4-(трифторметил)фенил]-6,7-дигидро-5H-имидазо[1,2-a][1,4]диазепин-8(9H)-ил}этил)-1,3-бензоксазол-2(3H)-она, имеющая характеристические пики при углах 2θ(°)6,7, 13,6, 15,2, 15,6, 18,5, 19,4, 20,4, 23,3,25,5, 26,6.
2. Кристаллическая форма 4-фтор-3-(2-оксо-2-{2-[4-(трифторметил)фенил]-6,7-дигидро-5H-имидазо[1,2-a][1,4]диазепин-8(9H)-ил}этил)-1,3-бензоксазол-2(3H)-она, имеющая характеристические пики при углах 2θ(°) 7,0, 9,4, 12,3, 15,8, 17,4, 18,9, 19,6, 21,3, 23,8, 25,0.
RU2020103225A 2015-06-19 2016-06-17 Имидазодиазепиновое соединение RU2777915C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015-123478 2015-06-19
JP2015123478 2015-06-19

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2018101861A Division RU2712968C2 (ru) 2015-06-19 2016-06-17 Имидазодиазепиновое соединение

Publications (3)

Publication Number Publication Date
RU2020103225A true RU2020103225A (ru) 2020-02-04
RU2020103225A3 RU2020103225A3 (ru) 2022-02-18
RU2777915C2 RU2777915C2 (ru) 2022-08-11

Family

ID=

Also Published As

Publication number Publication date
EP3312181B1 (en) 2019-08-07
CA2989982A1 (en) 2016-12-22
AR105025A1 (es) 2017-08-30
MY197499A (en) 2023-06-19
EP3312181A1 (en) 2018-04-25
CN111205292B (zh) 2022-06-21
AU2016279518B2 (en) 2020-01-16
HUE047430T2 (hu) 2020-04-28
KR102591169B1 (ko) 2023-10-18
CA2989982C (en) 2023-08-15
LT3312181T (lt) 2019-10-10
SG11201710345VA (en) 2018-01-30
CO2018000431A2 (es) 2018-04-10
CN111205292A (zh) 2020-05-29
KR20180014732A (ko) 2018-02-09
RU2018101861A3 (ru) 2019-08-06
JP6658753B2 (ja) 2020-03-04
TW201713662A (zh) 2017-04-16
ES2751913T3 (es) 2020-04-02
MX2017016690A (es) 2018-03-15
CY1122232T1 (el) 2020-11-25
JPWO2016204268A1 (ja) 2018-04-05
RS59497B1 (sr) 2019-12-31
WO2016204268A1 (ja) 2016-12-22
DK3312181T3 (da) 2019-10-28
CN107635996A (zh) 2018-01-26
ZA201708566B (en) 2019-06-26
PT3312181T (pt) 2019-10-29
US20180185383A1 (en) 2018-07-05
IL256252A (en) 2018-02-28
PH12017502253A1 (en) 2018-05-28
HRP20191961T1 (hr) 2020-02-07
EP3312181A4 (en) 2018-11-21
PL3312181T3 (pl) 2020-01-31
CN107635996B (zh) 2020-05-26
TWI697496B (zh) 2020-07-01
UA120006C2 (uk) 2019-09-10
RU2018101861A (ru) 2019-07-19
AU2016279518A1 (en) 2018-01-04
SI3312181T1 (sl) 2020-02-28
IL256252B (en) 2021-01-31
RU2020103225A3 (ru) 2022-02-18
RU2712968C2 (ru) 2020-02-03
US10426784B2 (en) 2019-10-01

Similar Documents

Publication Publication Date Title
IL277576A (en) Mutated pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
IL265918B (en) Converted pyrazolo[1,5–a]pyridine compounds as ret kinase inhibitors
DK3478682T3 (da) [1,2,4]triazolo[1,5-a]pyridinylsubstituerede indolforbindelser
HK1245764A1 (zh) 3-取代的5-氨基-6h-噻唑並[4,5-d]嘧啶-2,7-二酮化合物
HK1246792A1 (zh) 6,7-二氫吡唑並[1,5-a]吡嗪-4(5h)-酮化合物
PL3345907T3 (pl) Związki pirazolo[3,4-d]pirymidynowe lub ich sole
HUE043441T2 (hu) 2-((4S)-6-(4-klórfenil)-l-metil-4H-benzo[c]izoxazolo[4,5-e]azepin-4-il)acetamid kristályos formái
IL274037A (en) A pyrimidine compound as a JAK kinase inhibitor
EP3505171A4 (en) BICYCLIC NITROGENATED HETEROCYCLIC COMPOUND
IL262673A (en) A pyrazolo[5,1-a]pyrimidine compound
ZA201605666B (en) Pyrazolo[1,5-a]pyrimidines as antiviral compounds
RU2020103225A (ru) Имидазодиазепиновое соединение
PT3484892T (pt) Derivados de 1,2,4-triazolo-[3,4-b]-1,3,4-tiadiazole
MA42544A (fr) COMPOSÉ PYRROLO[2,3-d]PYRIMIDINE OU UN SEL DE CELUI-CI
SG11201605182PA (en) CRYSTALS (2) OF PYRAZINO[2,1-c][1,2,4]TRIAZINE COMPOUND
HUE050298T2 (hu) Pirazolo[3,4-D]pirimidin vegyületek vagy annak sói